Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Technical Chemical & Products (TCPI) -- Ignore unavailable to you. Want to Upgrade?

To: Brander who wrote (80)	2/23/1998 3:06:00 AM
From: go4it	Respond to of 111

Brad, He certainly has all the earmarks of one. It looks like a classic case of bad mouth a company in a really harsh manner with nothing to back it up. They will never substantiate their claims because that takes too much intellect. I am still on the sidelines in regards to TCPI but whenever I see a short post, the word neandrathol always seems to pop into my head for some reason.

To: Brander who wrote (80)	2/24/1998 2:29:00 AM
From: CLEMENZA	Read Replies (1) \| Respond to of 111

1) You obviously do not do much research - you can get into big companies if you are persistent and know what you are doing. 2) I am long ten times more than short, but not bad companies that that are overvalued. 3) I have yet to find anyone credible who believe's that TCPI'S so called non invasive glucose monitor works or that it will ever work or be be successful. Who have you talked to, Aronowitz ? 4) It now appears that SK/Glaxo deal is dead. Are you going to suggest to me that SK will now come back to the TCPI table ? Wake up and smell the coffee.